Skip to main content

Avanos Medical, Inc. (AVNS)

NYSE: AVNS · IEX Real-Time Price · USD
32.10 -0.56 (-1.71%)
Oct 26, 2021 3:09 PM EDT - Market open

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year2020201920182017201620152014201320122011
Revenue
714.8697.6652.3611.6566.25091,672.11,677.51,6841,659.9
Revenue Growth
2.47%6.94%6.65%8.02%11.24%-69.56%-0.32%-0.39%1.45%-
Cost of Revenue
341.5295.4261.4274.7269251.21,123.51,065.31,081.51,069.1
Gross Profit
373.3402.2390.9336.9297.2257.8548.6612.2602.5590.8
Selling, General & Admin
332.6399.1340.4321.7346.2349.7424.5351.4343351.7
Research & Development
34.937.741.838.238.427.633.637.93331.2
Operating Expenses
367.5436.8382.2359.9384.6377.3458.1389.3376382.9
Operating Income
5.8-34.68.7-23-87.4-119.590.5222.9226.5207.9
Interest Expense / Income
15.61526.431.632.733.160.10.80.2
Other Expense / Income
50.714.4-65.6-93.8-104341-6.7-5-4.1-6.9
Pretax Income
-60.5-6447.939.2-16.1-493.691.2227.8229.8214.6
Income Tax
-33.3-18.1-9.6-40.1-55.9-67.364.173.277.272.2
Net Income
-27.2-45.957.579.339.8-426.327.1154.6152.6142.4
Net Income Common
-27.2-45.957.579.339.8-426.327.1154.6152.6142.4
Net Income Growth
---27.49%99.25%---82.47%1.31%7.16%-
Shares Outstanding (Basic)
4848474747474747--
EPS (Basic)
-0.57-0.961.221.690.85-9.150.583.323.28-
EPS (Diluted)
-0.57-0.961.221.690.85-9.150.583.323.28-
EPS Growth
---27.81%98.82%---82.53%1.22%--
Free Cash Flow Per Share
-0.47-2.61-4.112.163.490.751.663.76--
Gross Margin
52.22%57.65%59.93%55.09%52.49%50.65%32.81%36.49%35.78%35.59%
Operating Margin
0.81%-4.96%1.33%-3.76%-15.44%-23.48%5.41%13.29%13.45%12.52%
Profit Margin
-3.81%-6.58%8.81%12.97%7.03%-83.75%1.62%9.22%9.06%8.58%
Free Cash Flow Margin
-3.18%-17.93%-29.85%16.53%28.77%6.88%4.62%10.44%9.64%6.25%
Effective Tax Rate
55.04%28.28%-20.04%-102.30%347.20%13.63%70.29%32.13%33.59%33.64%
EBITDA
-2-12.1107.8130.381.8-395.1182.6297.1288.2265.9
EBITDA Margin
-0.28%-1.73%16.53%21.30%14.45%-77.62%10.92%17.71%17.11%16.02%
EBIT
-44.9-4974.370.816.6-460.597.2227.9230.6214.8
EBIT Margin
-6.28%-7.02%11.39%11.58%2.93%-90.47%5.81%13.59%13.69%12.94%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).